Skip to main content

Table 1 Sociodemographic, clinical, and hematological variables of the patients with pediatric ALL included in the study (n = 69)

From: Clinical characteristics and outcomes of patients with pediatric acute lymphoblastic leukemia after induction of chemotherapy: a pilot descriptive correlational study from Palestine

Variable n %
Age (years)
 < 10 26 37.7
 ≥ 10 43 62.3
Gender
 Male 42 60.9
 Female 27 39.1
Presence of abdominal pain
 Yes 22 31.9
 No 47 68.1
Presence of fever
 Yes 37 53.6
 No 32 46.4
Presence of bone pain
 Yes 30 43.5
 No 39 56.5
CNS statusa
 CNS 1 66 95.7
 CNS 2 1 1.4
 CNS 3 2 2.9
Presence of pallor
 Yes 50 72.5
 No 19 27.5
Presence of anorexia
 Yes 9 13
 No 60 87
Presence of hepatomegalyb
 Yes 34 49.3
 No 35 50.7
Presence of splenomegalyc
 Yes 34 49.3
 No 35 50.7
Presence of bleedingd
 Yes 15 21.7
 No 54 78.3
Immunophenotype
 B-ALL 55 79.7
 T-ALL 14 20.3
Cytogenetics for B-ALL
 t(12, 21) 10 18.2
 Hyperdiploidy 5 9.1
 t(1, 19) 4 7.3
 t(9, 22) 2 3.6
 Nil 19 34.5
 Missing 15 27.3
Relapsee
 Yes 5 7.2
 No 64 92.8
Remissionf
 Yes 68 98.5
 No 1 1.5
 Hematological laboratory data at admission Median IQR
 Hemoglobin (g/dL) 9.0 2.7
 Platelet count (per mm3) 80000 157000
 Initial WBCs count (cells/mm3) 7100 20600
 Absolute neutrophils count (cells/mm3) 1420 2030
  1. IQR interquartile range, WBCs white blood cells
  2. aCNS1: WBC in CSF < 5 without WBC blasts, CNS2: WBC in CSF < 5 with WBC blasts, CNS3: WBC in CSF > 5 with WBC blasts
  3. bHepatomegaly: palpable liver below the costal margin
  4. cSplenomegaly: palpable spleen
  5. dPresence of bleeding symptoms like petechiae, epistaxis, bruising, gum bleeding, blood in stool
  6. eRelapse: patient was in remission and developing any of the following: 1. More than 20% of blasts in bone marrow, or, 2. CNS status 2 or 3, or, 3. Both 1 + 2
  7. fRemission: the percentage of blast cells in the bone marrow is less than 5% at the end of induction of chemotherapy